Cryoport, Inc.
NASDAQ:CYRXIntegrated Freight & Logistics
+$0.19 today
- Market cap
- $999.81M
- Beta
- 1.89
- P/E (TTM)
- 9.5
- EPS (TTM)
- $1.55
Volume 0.82M
Average 0.69M
CYRX EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Cryoport, Inc.NASDAQ: CYRX
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$2.49M, compared with -$565K a year earlier. Trailing-twelve-month EBITDA was -$6.31M.
Context
- EBITDA amounted to 1.2% of revenue in FY2025, down 27.3 pp from a year earlier.
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 6 analysts of -$11.69M (-457.5%) for the fiscal year ending Dec 2026, a slowdown from the +96.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$2.49M-513.3% QoQ
- Last fiscal yearDec 2025
- -$2.1M+96.8% YoY
- LTMMar 2026
- -$6.31M+90.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -340.7% | +29.8% | +370.5 pp |
| 1 year | +96.8% | -457.5% | -554.4 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (2.1M) USD
- Year-over-year change
- +96.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.1M) | +96.8% |
| FY2024 | 2024-12-31 | (66.36M) | -972.5% |
| FY2023 | 2023-12-31 | (6.19M) | +97.5% |
| FY2022 | 2022-12-31 | (248.91M) | +0.0% |
| FY2021 | 2021-12-31 | (248.91M) | — |
EBITDA vs competitors
How CYRX compares with its peers on the latest reported figures
- CYRX's LTM Mar 2026 EBITDA of -$6.31M is the highest of the 2 companies compared; the peer median is -$94.49M.
- Its year-over-year change of +90.7% is the highest of 2, against a peer median of -265.1%.
- EBITDA amounts to 3.5% of revenue for CYRX, versus a peer median of 15.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | -$6.31M | +90.7% | — | 3.5% | |
| LTM Sep 2026 | -$94.49M | -265.1% | — | 15.2% | |
| Peer median (excluding CYRX) | -$94.49M | -265.1% | — | 15.2% | |
Competitors are the stored peer set for CYRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 222.61M | 222.61M | 237.28M | 233.26M | 176.18M |
| Cost of Revenue | 126.03M | 126.03M | 133.4M | 133.92M | 93.12M |
| Gross Profit | 96.58M | 96.58M | 103.87M | 99.33M | 83.05M |
| Gross Margin | 43.4% | 43.4% | 43.8% | 42.6% | 47.1% |
| Research & Development | 16.84M | 16.84M | 15.72M | 18.04M | 17.04M |
| Selling, General & Admin | 97.56M | 97.56M | 120.06M | 146.88M | 102.82M |
| Operating Expenses | 114.41M | 114.41M | 135.78M | 214.49M | 119.86M |
| Depreciation & Amortization | 20.25M | 20.25M | 22.77M | 27.49M | 27.71M |
| EBITDA | (248.91M) | (248.91M) | (6.19M) | (66.36M) | (2.1M) |
| EBITDA Margin | -111.8% | -111.8% | -2.6% | -28.4% | -1.2% |
| Operating Income | (17.83M) | (17.83M) | (31.9M) | (115.16M) | (36.81M) |
| Operating Margin | -8.0% | -8.0% | -13.4% | -49.4% | -20.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.69M | 4.69M | 6.14M | 5.5M | 2.36M |
| Other Income / Expenses | (256.01M) | (256.01M) | (3.19M) | 15.81M | 4.64M |
| Income Before Tax | (273.84M) | (273.84M) | (35.09M) | (99.35M) | (32.17M) |
| Pre-Tax Margin | -123.0% | -123.0% | -14.8% | -42.6% | -18.3% |
| Income Tax Expense | 1.69M | 1.69M | 2.24M | 239K | 1.8M |
| Net Income | (275.53M) | (275.53M) | (37.33M) | (99.59M) | 78.3M |
| Net Margin | -123.8% | -123.8% | -15.7% | -42.7% | 44.4% |
| EPS (Basic) | (6.18) | (6.18) | (0.93) | (2.21) | 1.40 |
| EPS (Diluted) | (6.18) | (6.18) | (0.93) | (2.21) | 1.40 |
| Weighted Avg Shares | 45.93M | 45.93M | 48.99M | 48.74M | 50.07M |
| Weighted Avg Shares (Diluted) | 45.93M | 45.93M | 48.99M | 48.74M | 50.07M |
Cryoport, Inc.
NASDAQ:CYRX
Intrinsic Alpha fair value
Locked
Current Price
$19.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.